UA was negative and blood and urine cultures obtained.
CXR was performed which was negative for any intra-thoracic process but demonstrated interval increase in osteous mets.
A CTA showed stable ground glass opacities, no PE or infiltrate.
An EKG was consistent with sinus tachycardia.
Per chart biopsy outpatient HR: 105-120s ST. .
Past Medical History: ONCOLOGIC HISTORY: # Early stage lung cancer status post right upper lobectomy and mediastinal lymph node dissection in [**2134-9-6**] without evidence of recurrence # Rectal Cancer: T3N2M0; diagnosed in [**9-/2141**] - [**2141-9-6**]: the pt develops abdominal pain and lower GI bleed, further investigation by colonoscopy reveals an ulcerated 4-5 cm mass in the mid rectum at 10cm, the pathology examination of the biopsies shows poorly differentiated carcinoma.
- [**2142-3-7**]: the patient undergoes low anterior resection and diverting loop ileostomy and mesenteric and periaortic lymphadenectomy (T3N2M0, [**8-17**] lymph nodes involved, with a distal margin that was clear by < 1 mm, k-RAS wild time) after completion of neo-adjuvant capecitabine-based chemoradiation - [**5-14**] the patient started adjuvant therapy with FLOX (5-FU + leucovorin 500 mg/m2 on day 1, 8, and 15 and oxaliplatin 85 mg on day 1,5 of four-week cycles).
- [**2142-7-7**] bone scan and spine MRI showed multiple bone metastasis, in [**2143-6-6**] a bone scan and now CT scan torso showed progression of bone metastates, but no evidence of other site of metastatic disease.
- [**2143-7-24**] start palliative chemotherapy with single [**Doctor Last Name 360**] Irinotecan (350 mg/m2 q21d) - [**2143-10-9**] CT TORSO showed increased sclerotic bony metastatic disease unclear if due to disease progression or response to treatment.
Treatment History: 06/09,16,23: C1 FLOX (5-FU 500 mg/m2 D1,8,21 + Oxaliplatin 85 mg/m2 D1,15) [**2142-6-13**]: C2 FLOX *C2D1 changed from [**6-10**] to [**6-12**] due to development of abdominal pain and nausea.
Urgent CT demonstrated nonocclusive thrombus of left renal vein and interval enlargement of sclerotic focus in left aspect of T12.
*Hospitalized [**Date range (1) 101702**] for neutropenic fevers (100.5, ANC 500,) LLQ pain, and dehydration.
CT demonstrated small bowel thickening suggestive of enteritis.
Stool and blood cultures negative.
CT revealed epiploic appendagitis.
[**2142-8-21**]: C4 FLOX (5-FU 400 mg/m2 D1,15 + Oxaliplatin 85 mg/m2 D1,15) [**2142-9-18**]: C5 FLOX [**2142-10-16**]: C6 FLOX [**2143-7-24**]: Start Irinotecan (350 mg/m2 q21d) .
Strength 5/5 in upper and lower extremities.
Pertinent Results: On Admission [**2143-12-29**] 04:45PM   WBC-10.8# RBC-3.73* HGB-10.4* HCT-30.8* MCV-83 MCH-27.9 MCHC-33.7 RDW-15.7* [**2143-12-29**] 04:45PM   PLT COUNT-271 [**2143-12-29**] 04:45PM   NEUTS-71* BANDS-2 LYMPHS-4* MONOS-21* EOS-0 BASOS-1 ATYPS-1* METAS-0 MYELOS-0 [**2143-12-29**] 04:45PM   HYPOCHROM-NORMAL ANISOCYT-1+ POIKILOCY-1+ MACROCYT-NORMAL MICROCYT-1+ POLYCHROM-NORMAL OVALOCYT-2+ TEARDROP-OCCASIONAL [**2143-12-29**] 04:45PM   GLUCOSE-130* UREA N-14 CREAT-1.2 SODIUM-135 POTASSIUM-4.1 CHLORIDE-100 TOTAL CO2-24 ANION GAP-15 [**2143-12-29**] 04:57PM   LACTATE-1.3 [**2143-12-29**] 04:45PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.019 [**2143-12-29**] 04:45PM URINE  BLOOD-SM NITRITE-NEG PROTEIN-150 GLUCOSE-NEG KETONE-TR BILIRUBIN-NEG UROBILNGN-NEG PH-6.5 LEUK-NEG [**2143-12-29**] 04:45PM URINE  RBC-0-2 WBC-0 BACTERIA-RARE YEAST-NONE EPI-0-2 .
Micro: Urine cx [**2143-12-30**] 4:32 pm URINE      Source: CVS.
**FINAL REPORT [**2143-12-31**]**     URINE CULTURE (Final [**2143-12-31**]):    NO GROWTH .
Blood cx: pending .
MICROSPORIDIA STAIN (Final [**2143-12-31**]):    NO MICROSPORIDIUM SEEN.
CYCLOSPORA STAIN (Final [**2143-12-31**]):    NO CYCLOSPORA SEEN.
FECAL CULTURE (Pending):     CAMPYLOBACTER CULTURE (Pending):     OVA + PARASITES (Final [**2143-12-31**]):       NO OVA AND PARASITES SEEN.
CLOSTRIDIUM DIFFICILE TOXIN A & B TEST (Final [**2143-12-31**]):       Feces negative for C.difficile toxin A & B by EIA.
Refer to respiratory viral culture for further information.
Plan: # Fevers: On admission patient with temperature of 102.
UA, urine culture was negative.
Blood cultures with no growth.
Hypertension: Pt initial BP is 195/87.
TTE obtained which was grossly normal (EF>55%) with exception of 1+ mitral regurgitation.
TSH wnl, CTA neg for PE.
Patient started on metoprolol for blood pressure and rate control.
With addition of nodal [**Doctor Last Name 360**] and better control of pain heart rates stable, 110s-120s, prior to discharge.
#.Metastatic rectal cancer/Back pain: Pt currently on palliative chemotherapy with single [**Doctor Last Name 360**] Irinotecan s/p cycle 7 on [**2143-12-4**].
CXR and CTA demonstrate progressive bone metastasis with worsening pain.
Outpatient pain regimen uptitrated; at time of discharge from the [**Hospital Unit Name 153**] patient on Oxycontin 80 mg SR [**Hospital1 **], oxycodone 10mg Q4, dilaudid 2mg Q3, a lidocaine patch and home neurotonin.
- Oxycontin was increased to 80mg q8 with oxycodone 15mg q4prn in addition to tylenol 650mg q4, gabapentin 300mg TID, lidocaine patch.
# Comm: Wife [**Name2 (NI) 101704**] [**Telephone/Fax (1) 101705**]   Medications on Admission: Albuterol nebs Benzonatate 100mg TID prn Citalopram 10mg daily Lovenox 80mg daily Fluticasone propionate Advair 500/50 2 puffs [**Hospital1 **] Loperamide 2mg q3:prn Lorazepam 2mg 1-2 tabs qhs:prn Omeprazole 40mg daily Oxycodone 5mg 1-2 tabs q4:prn Oxycontin 40mg [**Hospital1 **] KCL 20mEq SR [**Hospital1 **] Prochlorperazine maleate 10mg q6:prn Tamsulosin 0.4mg qhs Ambien 5mg qhs:prn   Discharge Medications: 1. benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3 times a day).
Release 24 hr Sig: One (1) Capsule, Sust.
Release 24 hr PO HS (at bedtime).
Disp:*60 Tablet(s)* Refills:*2* 19. polyethylene glycol 3350 17 gram/dose Powder Sig: One (1) packet PO DAILY (Daily) as needed for constipation.
Discharge Instructions: You were admitted for evaluation of fever and back pain.
